期刊名称：GENE THERAPY AND MOLECULAR BIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Gene Therapy and Molecular Biology, bridging various fields is one of the most rapid with free access at gtmb.org.
The scope of Gene Therapy and Molecular Biology is to promote interaction between researchers in the fields of Gene Therapy and Molecular Biology providing rapid publication of review articles and research papers. Articles, both invited and submitted, review or report novel findings of importance to a general audience in gene therapy, molecular medicine, gene discovery, and molecular biology with emphasis to molecular mechanisms. The journal will accept papers on all aspects of gene therapy including gene delivery systems, gene therapy of cancer and other diseases (e.g. CFTR, hemophilia, AIDS, restenosis) at the clinical, preclinical or cell culture stage, gene discovery, cancer immunotherapy, DNA vaccines, use of DNA regulatory elements in gene transfer, cell therapy and transplantation, arraying technologies & DNA chips, peptide libraries and drug discovery related to gene therapy, cell targeting, gene targeting, therapy with oligonucleotides (antisense, ribozymes, triplex). The authors are encouraged to elaborate on the molecular mechanisms that govern a gene therapy approach. Gene Therapy and Molecular Biology will also publish articles on, transcription factors, DNA replication, recombination, repair, chromatin, nuclear matrix, DNA regulatory regions, locus control regions, protein phosphorylation, signal transduction, development, and on molecular mechanism of human disease. To make the publication attractive authors are encouraged to include color figures.
Instructions to Authors
Both review and original research articles will be considered. In addition, short 1-2 page news & views will also be considered for publication. Original research articles should contain a generous introduction in addition to experimental data. The articles contain information important to a general audience as the volume is also addressed to researchers outside the field. There is no limit on the length of the articles provided that the subject is interesting to a general audience and covers exhaustively a field. The typical length of each manuscript is approximately 4-20 printed page including Figures and Tables, meaning 12-60 manuscript pages.
|
Charges, Complimentary reprints & Subscriptions |
There are no charges for color figures or number of pages submitted. Corresponding authors get a one-year free subscription (hard copy) plus 25 reprints free of charge. The free subscription can be renewed for additional years by having one paper per year accepted for publication The free electronic access to articles published in "Gene Therapy and Molecular Biology" to a big general audience, the attractive journal title, the speed of the reviewing process, the no-charges for number of pages or color figure reproduction, the 25 complimentary reprints, the rapid electronic publication, the embracing of many fields in gene therapy (from molecular mechanisms to clinical trials), the high quality in-depth reviews and first rate research articles, as well as (and most importantly) the eminent members of the Editorial Board being assembled, are prognostic factors of significant success for GTMB.
|
Sections of the manuscript |
Each manuscript should have a Title, Authors, Affiliation, Corresponding Author (with Tel, Fax, and E-mail), Summary, key words , running title and Introduction; review articles are subdivided into headings I, II, III, etc. (starting with I. Introduction) subdivided into A, B, C, and further subdivided using 1, 2, 3, etc. You can further subdivide into 1, 2, 3, etc. Research articles are divided into Summary; I. Introduction; II. Materials and Methods III. Results; IV. Discussion; Acknowledgments; and References. Please include in your text citations the name of authors and year in parenthesis; for three or more authors use: (name of first author et al, with year); for two authors please use both names. Please delete hidden text for references. In the reference list, please, type references with year and Journal in boldface and provide full title of the article such as:
Buschle M, Schmidt W, Berger M, Schaffner G, Kurzbauer R, Killisch I, Tiedemann J-K, Trska B, Kirlappos H, Mechtler K, Schilcher F, Gabler C, and Birnstiel ML (1998) Chemically defined, cell-free cancer vaccines: use of tumor antigen-derived peptides or polyepitope proteins for vaccination. Gene Ther Mol Biol 1, 309-321.
To avoid delays it is essential to submit an electronic and a hard copy version of your manuscript via e-mail and mail in a floppy, CD-ROM or ZIP, containing the manuscript that will be used to typeset the paper. Please include in the digital media: Tables, if any, (preferably as a Microsoft Word text) and Figure legends. Please use Microsoft Word, font ?B>Times?(Mac users) or 揟imes New Roman?(PC users) and insert Greek or other characters using the ?B>Insert/Symbol?function in the Microsoft Word rather than simple conversion to font 揝ymbol? Please boldface Figure 1, 2, 3 etc. as well as Table 1, 2, etc. throughout the text. Please provide the highest quality of prints of your Figures; whenever possible, please provide in addition an electronic version of your figures.
Article contributors are kindly requested to provide a color (or black/white) photo of themselves (preferably 4x5 cm or any size) or a group photo of the authors, as we shall include these in the publication.
Peer reviewing is by members of the Editorial Board and external referees. Please suggest 2-3 reviewers providing their electronic addresses, mailing addresses and telephone/fax numbers.
Authors are sent page proofs.
Gene Therapy and Molecular Biology is published on high quality paper, hardbound, and with excellent reproduction of color figures.
Reviewing is completed within 5-15 days from receiving the manuscript.
Articles accepted without revisions (i.e., review articles) will be published online (www.gtmb.org) in approximately 1 month following submission.
Please submit an electronic version of full text and figures, preferably in jpeg format. The electronic version of the figures will be used for the rapid reviewing process. High quality prints or photograph of the figures and the original with one copy should be sent via express mail to the Editorial Office.
By Mail:
Editorial Office
Gene Therapy & Molecular Biology
Cancer Therapy
Teni Boulikas, Ph.D., Editor and Publisher
Panagiotis Kourtesis, Ph.D., Managing Editor
Afxentiou 7
Alimos, Athens 17455
Greece
Tel: +30-210-9847-975
Fax: +30-210-9858-453
Electronically:
Panagiotis Kourtesis, Ph.D., Managing Editor
p.kourtesis@cancer-therapy.org
pikourtesis@regulon.org
Maria Vougiouka
maria@cancer-therapy.org
Adrian Kruit, Ph.D. (web content)
adrian@cancer-therapy.org
Assistants
Angela Ladopoulou, Ph.D.
angela.ladopoulou@cancer-therapy.org
Jenny Katsoupi, M.Sc.
jenny7@cancer-therapy.org
Articles accepted for publication by GTMB or Cancer Therapy can be included in MedLine (PubMed) as full articles upon the request of authors provided that the authors have completed their published work under a government grant by NIH (or EU/Japan government grant). If this is you case, please consult the NIH Manuscript Submission System http://www.nihms.nih.gov/.
Gene Therapy and Molecular Biology (GTMB) is covered in the following Thomson Scientific services:
Science Citation Index Expanded (also known as SciSearch)
Biotechnology Citation Index
Journals Citation Reports/Science Edition
Editorial Board
GENE THERAPY & MOLECULAR BIOLOGY
FREE ACCESS www.gtmb.org
!!!!!!!!!!!!!!!!!!!!!!!!
Editor
Teni Boulikas Ph. D.,
CEO Regulon Inc.
715 North Shoreline Blvd.
Mountain View, California, 94043
USA
Tel: 650-968-1129
Fax: 650-567-9082
E-mail: teni@regulon.org
Teni Boulikas Ph. D.,
CEO, Regulon AE.
Gregoriou Afxentiou 7
Alimos, Athens, 17455
Greece
Tel: +30-210-9853849
Fax: +30-210-9858453
E-mail: teni@regulon.org
!!!!!!!!!!!!!!!!!!!!!!!!
Assistant to the Editor
Maria Vougiouka B.Sc.,
Gregoriou Afxentiou 7
Alimos, Athens, 17455
Greece
Tel: +30-210-9858454
Fax: +30-210-9858453
E-mail: maria@cancer-therapy.org
!!!!!!!!!!!!!!!!!!!!!!!!
Associate Editors
Aguilar-Cordova, Estuardo, Ph.D., AdvantaGene, Inc., USA
Berezney, Ronald, Ph.D., State University of New York at Buffalo, USA
Crooke, Stanley, M.D., Ph.D., ISIS Pharmaceuticals, Inc, USA
Crouzet, Jo雔, Ph.D. Neurotech S.A, France
Gronemeyer, Hinrich, Ph.D. I.N.S.E.R.M., IGBMC, France
Rossi, John, Ph.D., Beckman Research Institute of the City of Hope, USA
Shen, James, Ph.D., Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China & University of
California at Davis, USA.
Webb, David, Ph.D., Celgene Corporation, USA
Wolff, Jon, Ph.D., University of Wisconsin, USA
!!!!!!!!!!!!!!!!!!!!!!!!
Editorial Board
Akporiaye, Emmanuel, Ph.D., Arizona Cancer
Center, USA
Anson, Donald S., Ph.D., Women's and Children's
Hospital, Australia
Ariga, Hiroyoshi, Ph.D., Hokkaido University,
Japan
Baldwin, H. Scott, M.D Vanderbilt University
Medical Center, USA
Barranger, John, MD, Ph.D., University of
Pittsburgh, USA
Black, Keith L. M.D., Maxine Dunitz Neurosurgical
Institute, Cedars-Sinai Medical Center, USA
Blum, Kenneth, Ph.D., Wake Forest University
School of Medicine, USA
Bode, J黵gen, Gesellschaft f黵 Biotechnologische
Forschung m.b.H., Germany
Bohn, Martha C., Ph.D., The Feinberg School of
Medicine, Northwestern University, USA
Bresnick, Emery, Ph.D., University of Wisconsin
Medical School, USA
Caiafa, Paola, Ph.D., Universit?di Roma 揕a
Sapienza? Italy
Chao, Lee, Ph.D., Medical University of South
Carolina, USA
Cheng, Seng H. Ph.D., Genzyme Corporation, USA
Clements, Barklie, Ph.D., University of Glasgow,
USA
Cole, David J. M.D., Medical University of South
Carolina, USA
Chishti, Athar H., Ph.D., University of Illinois
College of Medicine, USA
Davie, James R, Ph.D., Manitoba Institute of Cell
Biology;USA
DePamphilis, Melvin L, Ph.D., National Institute of
Child Health and Human, National Institutes of Health,
USA
Donoghue, Daniel J., Ph.D., Center for Molecular
Genetics, University of California, San Diego, USA
Eckstein, Jens W., Ph.D., Akikoa Pharmaceuticals
Inc, USA
Fisher, Paul A. Ph.D., State University of New York,
USA
Galanis, Evanthia, M.D., Mayo Clinic, USA
Gardner, Thomas A, M.D., Indiana University
Cancer Center, USA
Georgiev, Georgii, Ph.D., Russian Academy of
Sciences, USA
Getzenberg, Robert, Ph.D., Institute Shadyside
Medical Center, USA
Ghosh, Sankar Ph.D., Yale University School of
Medicine, USA
Gojobori, Takashi, Ph.D., Center for Information
Biology, National Institute of Genetics, Japan
Harris David T., Ph.D., Cord Blood Bank, University
of Arizona, USA
Heldin, Paraskevi Ph.D., Uppsala Universitet,
Sweden
Hesdorffer, Charles S., M.D., Columbia University,
USA
Hoekstra, Merl F, Ph.D., Epoch Biosciences, Inc.,
USA
Hung, Mien-Chie, Ph.D., The University of Texas,
USA
Johnston, Brian, Ph.D., Somagenics, Inc, USA
Jolly, Douglas J, Ph.D., Advantagene, Inc.,USA
Joshi, Sadhna, Ph.D., D.Sc., University of Toronto
Canada
Kaltschmidt, Christian, Ph.D., Universit鋞
Witten/Herdecke, Germany
Kiyama, Ryoiti, Ph.D., National Institute of
Bioscience and Human-Technology, Japan
Krawetz, Stephen A., Ph.D., Wayne State
University School of Medicine, USA
Kruse, Carol A., Ph.D., La Jolla Institute for
Molecular Medicine, USA
Kuo, Tien, Ph.D., The University of Texas M. D.
Anderson Cancer USA
Kurachi Kotoku, Ph.D., University of Michigan
Medical School, USA
Kuroki, Masahide, M.D., Ph.D., Fukuoka
University School of Medicine, Japan
Lai, Mei T. Ph.D., Lilly Research Laboratories USA
Latchman, David S., PhD, Dsc, MRCPath
University of London, UK
Lavin, Martin F, Ph.D., The Queensland Cancer
Fund Research Unit, The Queensland Institute of
Medical Research, Australia
Lebkowski, Jane S., Ph.D., GERON Corporation,
USA
Li, Jian Jian, Ph.D., City of Hope National Medical
Center, USA
Li, Liangping Ph.D., Max-Delbr點k-Center for
Molecular Medicine, Germany
Lu, Yi, Ph.D., University of Tennessee Health Science
Center, USA
Lundstrom Kenneth, Ph.D. , Bioxtal/Regulon, Inc.
Switzerland
Malone, Robert W., M.D., Aeras Global TB Vaccine
Foundation, USA
Mazarakis, Nicholas D. Ph.D., Imperial College
London, UK
Mirkin, Sergei, M. Ph.D., University of Illinois at
Chicago, USA
Moroianu, Junona, Ph.D., Boston College, USA
M黮ler, Rolf, Ph.D., Institut f黵 Molekularbiologie
und Tumorforschung, Phillips-Universit鋞 Marburg,
USA
Noteborn, Mathieu, Ph.D., Leiden University, The
Netherlands
Papamatheakis, Joseph (Sifis), Ph.D., Institute of
Molecular Biology and Biotechnology
Foundation for Research and Technology Hellas, USA
Platsoucas, Chris, D., Ph.D., Temple University
School of Medicine, USA
Rockson, Stanley G., M.D., Stanford University
School of Medicine, USA
Poeschla, Eric, M.D., Mayo Clinic, USA
Pomerantz, Roger, J., M.D., Tibotec, Inc., USA
Raizada, Mohan K., Ph.D., University of Florida,
USA
Razin, Sergey, Ph.D., Institute of Gene Biology
Russian Academy of Sciences, USA
Robbins, Paul, D, Ph.D., University of Pittsburgh,
USA
Rosenblatt, Joseph, D., M.D, University of Miami
School of Medicine, USA
Rosner, Marsha, R., Ph.D., Ben May Institute for
Cancer Research, University of Chicago, USA
Royer, Hans-Dieter, M.D., (CAESAR), Germany
Rubin, Joseph, M.D., Mayo Medical School
Mayo Clinic, USA
Saenko Evgueni L., Ph.D., University of Maryland
School of Medicine Center for Vascular and
Inflammatory Diseases, USA
Salmons, Brian, Ph.D., (FSG-Biotechnologie GmbH),
Austria
Santoro, M. Gabriella, Ph.D., University of Rome
Tor Vergata, USA
Sharrocks, Andrew, D., Ph.D., University of
Manchester, USA
Shi, Yang, Ph.D., Harvard Medical School, USA
Smythe Roy W., M.D., Texas A&M University
Health Sciences Center, USA
Srivastava, Arun Ph.D., University of Florida
College of Medicine, USA
Steiner, Mitchell, M.D., University of Tennessee,
USA
Tainsky, Michael A., Ph.D., Karmanos Cancer
Institute, Wayne State University, USA
Sung, Young-Chul, Ph.D., Pohang University of
Science & Technology, Korea
Taira, Kazunari, Ph.D., The University of Tokyo,
Japan
Terzic, Andre, M.D., Ph.D., Mayo Clinic College of
Medicine, USA
Thierry, Alain, Ph.D., National Cancer Institute,
National Institutes of Health, France
Trifonov, Edward, N. Ph.D., University of Haifa,
Israel
Van de Ven, Wim, Ph.D., University of Leuven,
Belgium
Van Dyke, Michael, W., Ph.D., The University of
Texas M. D. Anderson Cancer Center, USA
White, Robert, J., University of Glasgow, UK
White-Scharf, Mary, Ph.D., Biotransplant, Inc., USA
Wiginton, Dan, A., Ph.D., Children's Hospital
Research Foundation, CHRF , USA
Yung, Alfred, M.D., University of Texas, USA
Zannis-Hadjopoulos, Maria Ph.D., McGill Cancer
Centre, Canada
Zorbas, Haralabos, Ph.D., BioM AG Team, Germany
!!!!!!!!!!!!!!!!!!!!!!!!
Associate Board Members
Aggarwal, Priya, Ph.D., University of Pennsylvania,
USA
Aoki, Kazunori, M.D., Ph.D., National Cancer Center
Research Institute, Japan
Cao, Xinmin, Ph.D., Institute of Molecular and Cell
Biology, Singapore
Falasca, Marco, M.D., University College London,
UK
Gao, Shou-Jiang, Ph.D., The University of Texas
Health Science Center at San Antonio, USA
Gibson, Spencer Bruce, Ph.D., University of Manitoba,
USA
Gra馻, Xavier, Ph.D., Temple University School of
Medicine, USA
Gu, Baohua, Ph.D., The Jefferson Center, USA
Hiroki, Maruyama, M.D., Ph.D., Niigata University
Graduate School of Medical and Dental Sciences, Japan
MacDougald, Ormond A, Ph.D., University of
Michigan Medical School, USA
Rigoutsos, Isidore, Ph.D., Thomas J. Watson Research
Center, USA
For submission of manuscripts and inquiries:
Editorial Office
Teni Boulikas, Ph.D./ Maria Vougiouka, B.Sc.
Gregoriou Afxentiou 7
Alimos, Athens 17455
Greece
Tel: +30-210-985-8454
Fax: +30-210-985-8453
and electronically to
maria@cancer-therapy.org
|
刊名字顺( Alphabetical List of Journals):
返回页首 